NFKBIA and Hepatic fibrosis: Furthermore, TB001 attenuated liver fibrosis by inhibiting the downstream activation of the pro-inflammatory NF-kappa-B inhibitor alpha (NFκB/IKBα) pathways and blocking the c-Jun N-terminal kinase (JNK)-dependent induction of hepatocyte apoptosis [87].